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Despite their extensive sequence identities at the amino acid level (-55%), NGF and brain-derived neurotrophic factor (BDNF) display distinct neuronal specificity toward neurons of both the PNS and CNS. To explore which region(s) within these neurotrophic factors might determine their differential actions on various subpopulations of peripheral neurons, a systematic series (homolog-scanning mutagenesis) of chimerit NGF/BDNF molecules was prepared using PCR overlap-extension techniques.
After expression in COS-7 cells, the chimeric proteins were tested for their biological activities in neurite outgrowth and neuronal survival assays. This approach led to the functional expression of 12 NGF/BDNF chimeras.
Surprisingly, despite replacing successive amino acid segments throughout the entire length of NGF with the corresponding parts of BDNF, all chimeras displayed full NGF-like activity in bioassays carried out with PC12 cells, embryonic chick dorsal root ganglion explants, sympathetic ganglion explants, and dissociated cultures of dorsal root ganglion neurons. Most of the chimeras additionally showed BDNF-like activity as defined by neurite outgrowth on chick nodose ganglion explants. However, none of the chimeras supported the survival of dissociated nodose ganglion neurons. Our results suggest that NGF and BDNF must share very similar higher-order protein structures, and we propose that the overall structure or conformation of NGF, in contrast to short amino acid "active-site" segments, may determine its exact neuronal specificity.
NGF is known to be involved in the regulation of neuronal survival during development, maintenance of the phenotype of mature neurons, and regeneration of injured neurons of the PNS (reviewed by Thoenen and Barde, 1980; Levi-Montalcini, 1987; Lindsay, 1988; Barde, 1989; Shooter, 1989) . In particular, NGF supports the survival of sympathetic neurons as well as a sub-population of neural crest-derived sensory neurons during development. Although initially described as a protein affecting neurons of the PNS, NGF has subsequently been shown to play a major role in the development and maintenance of at least one population of neurons of the CNS (reviewed by Thoenen et al., 1987; Whittemore and Seiger, 1987) . Numerous in vitro and in vivo studies have established that cholinergic neurons of the basal forebrain are responsive to NGF (Hefti, 1986; Williams et al., 1986; Kramer, 1987; Kntisel et al., 1990) . In conjunction with the demonstration that NGF treatment is able to rescue axotomized septal cholinergic neurons in the adult rat (Hefti, 1986) and to reverse specific behavioral deficits in aged rats (Fischer et al., 1987) , it has been suggested that NGF treatment may prevent the progressive loss of cholinergic neurons of the basal forebrain that occurs as a component of several dementias such as Alzheimer's disease (reviewed by Hefti and Weiner, 1986) . The restricted neuronal specificity of NGF predicted the existence of other neurotrophic factors, molecules with functional properties similar to NGF but different neuronal specificities. This rationale has lead to the discovery of the neurotrophin family of NGF-related neurotrophic factors, which at present includes, in addition to NGF, brain-derived neurotrophic factor (BDNF), neurotrophin-3 (NT-3) and the recently discovered neurotrophin4 (NT-4). BDNF was initially purified from porcine brain (Barde and Thoenen, 1982) and shown, like NGF, to support the survival of a subpopulation of sensory neurons of the developing chick embryo dorsal root ganglion (DRG) in vitro. Although exhibiting a common action toward DRG neurons in culture, BDNF and NGF were first distinguished on the basis that neutralizing antibodies against NGF had no effect upon BDNF. An even clearer distinction between NGF and BDNF was established when it was shown that BDNF supports the survival of a subpopulation of cultured placode-derived sensory neurons such as those of the nodose ganglion (NG), neurons known to be refractory to NGF (Lindsay and Rohrer, 1985; . Consistent with the in vitro findings, it was later shown that BDNF administration in ovo to developing quail embryos prevented naturally occurring cell death of both neural crest-derived neurons as well as placode-derived neurons of the NG (Hofer and Barde, 1988) . With regard to neurons of the CNS, it has recently been shown that BDNF has very similar actions compared to NGF in stimulating the survival and phenotypic differentiation of septal cholinergic neurons (Alderson et al., 1990; Kntisel et al., 199 1) . In striking contrast to NGF, however, BDNF has been found to be a neurotrophic factor for dopaminergic neurons of the developing substantia nigra and to protect these neurons from the neurotoxicity of both 6-hydroxydopamine and 1 -methyl-4-phenylpyridinium (MPTP) (Hyman et al., 1991) .
The molecular cloning of BDNF (Leibrock et al., 1989; Jones and Reichardt, 1990 ) revealed a striking similarity to NGF. Both growth factors are synthesized as larger precursors that are proteolytically processed to give rise to mature proteins of similar size (about 120 amino acids) and similar predicted biochemical properties. At the amino acid level, there is about 50% amino acid identity (depending on species differences) between the mature forms of NGF and BDNF. In particular, all six cysteine residues are perfectly conserved between both proteins, and only a few small gaps have to be introduced into the amino acid sequences for maximal alignments (Leibrock et al., 1989) . Interestingly, the mature form of BDNF has been found to be identical in all mammals examined (Maisonpierre et al., 199 1) . Such features predict a similar higher-order protein structure for NGF and BDNF. This hypothesis is indirectly supported by the fact that BDNF binds to the low-affinity NGF receptor (LNGFR; Johnson et al., 1986; Radeke et al., 1987 ) with a similar affinity but different kinetics than NGF (Rodriguez-Tebar and Rodriguez-Ttbar et al., 1990) . Despite their pronounced amino acid identities, NGF and BDNF display interesting differences in their neuronal specificity as well as potential overlap on other neurons as described above.
Based on the striking homology between NGF and BDNF, a third member of the neurotrophin family of NGF-related neurotrophic factors, NT-3 (also described as HDNF or NGF-2) has been molecularly cloned (Emfors et al., 1990; Hohn et al., 1990; Jones and Reichardt, 1990; Kaisho et al., 1990; MaisonPierre et al., 1990; Rosenthal et al., 1990) . NT-3 shares Xl-55% amino acid identity with NGF or BDNF, and the recombinant NT-3 protein displays a unique spectrum of biological activities. NT-3 elicits neurite outgrowth from explants of chick embryo DRG, sympathetic chain ganglia (SC), and NG (Maisonpierre et al., 1990) . In addition, NT-3 supports survival of dissociated NG neurons (Hohn et al., 1990) as well as DRG neurons (Rosenthal et al., 1990 ) and binds to the LNGFR (Rodriguez-TCbar et al., 1991; Squint0 et al., 1991) .
NT-4 was cloned very recently from Xenopus and Viperu (Hallbook et al., 199 1) . This fourth, as yet only partially characterized member of the neurotrophin family also interacts with the LNGFR and elicits neurite outgrowth from explants of chick DRG and NG. No activity was observed, however, on sympathetic ganglia.
In this report, we describe an examination of the structural basis within the NGF and BDNF molecules that might determine their different spectra of neuronal specificities. For this study, we have used the approach of homolog-scanning mutagenesis (Cunningham et al., 1989) . Segments of 8-12 amino acids of the BDNF sequence were sequentially introduced in the NGF molecule by replacing the corresponding NGF sequences. This method has the advantage that the small changes introduced in the mature NGF protein should not dramatically change the overall three-dimensional structure of the resulting chimeric proteins. It was hoped that this mutagenesis strategy might allow the identification of putative "recognition" or "active site" sequences that are responsible for the established neuronal specificity differences between these two highly related proteins. The chimeric molecules were transiently expressed in COS-7 cells, and their activity was compared in a PC12 cell bioassay. The neuronal specificity of each chimera toward three different subpopulations of peripheral neurons was established using explant and dissociated neuron-enriched cultures of chick embryo DRG, NG, and SC.
Materials and Methods

Materials
All restriction endonucleases were purchased from Bethesda Research Labs. Polymerase chain reaction (PCR) was performed using a Gene Amp Kit (Cetus). 35S-labeled cysteine (SJ-232) was purchased from Amersham.
Construction of chimeras
The cDNA encoding mouse NGF (Scott et al., 1983 ) was cut at its original Smal and Pstl restriction endonuclease sites and subcloned into the bluescript vector pKS (Stratagene). The resulting plasmid pKS-NGF served as a template for all the following PCR reactions (see also Horton et al., 1989) . Chimeric molecules were constructed by amplifying a S-fragment using the T7 primer (Stratagene; designated "A" in Fig. 1 ) together with an oligonucleotide primer spanning the desired parts of mouse NGF and mouse BDNF (primer "B" in Fig. 1) . A 3'-fragment was amplified using the T3 primer ("D" in Fig. 1 ) and a second designed NGF/BDNF primer (primer "c" in Fig. 1 ). The two resulting fragments were isolated and gel purified. In a second PCR-amplification sten, 1 OO-300 ng of each fragment were pooled, fused, and-amplified using the T7/T3 mimers. All PCR reactions were nerformed usine the followine step protocol in a Perkin Elmer thermal cycler. After a: initial denaturing incubation for 2 min at 94°C 25 cycles of amplifications were performed (1 min/94"C, 2 min/SO"C, 3 min/72"C) followed by a final extension at 72°C for 10 min. The resulting mutants were cloned into the SRa-promoter-based expression vector pBJ-5 (Takebe et al., 1988) . and the sequence of the entire preproNGF coding region was verified by dideoxynucleotide DNA sequencing (Sanger et al., 1977) to eliminate potential PCR-introduced mutations.
The following specific oligonucleotides were synthesized on PCRMate DNA synthesizer (Annlied Biosvstems) and used for the construction of the chimeric ne&nophic factors (see Fig. 1 ): Chimera-l/l B:
5'-CGGGCGGGGTCCGAGTGGGATGAGCGCTTGCTC-3' Chimera-l/ 1 C:
5'-CGGACCCCGCCCGCCGCGGGGAGTTCTCAGTGT-3' Chimera-2/2B: 5'-AATGCTCTCGCACACGCTCAGCTCCCCCATGTGGAA-3' Chimera-2/2C: 5'-CGTGTGCGACAGCATTAGCGAGTGGGTTGGAGATAAGA C-3' Chimera-3/3B: 5'-CCACTGCCGTCTTTTTATCCGCCGCCGTAACCCACACAC TGACAC-3' Chimera-313 C:
5'-TAAAAAGACGGCAGTGGACATGTCGGGTAAGGAGGTG ACAGTGC-3' Chimera-4/4 B:
S'-TTTCGAGGACCGTGACCGTGCCGCCCTTGATGTCTGTG-3' Chimera-4/4 C: 5'-GTCACGGTCCTCGAAAAAGTCAACATTAACAACAGTGTA TT-3' Chimera-5/5 B:
5'-GCCTTTCGAGACGGGCACCTCGGCCAGCAC-3' Chimera-5/5 C:
5'-CCCGTCTCGAAAGGCCAACTGAAGCAGTACTTTTTTGAG ACC-3' Chimera-6/B6: 5'-CTTGGTCTCATAAAAGTACTG-3' Chimera-6/C6: 5'-CAGTACTTTTATGAGACCAAG-3' Chimera-7/B7: 5'-TTTGTGTACCCCATAGGATTGCACTTGGTCTCAAAAAA-3' Chimera-7/C7: 5'-CCTATGGGGTACACAAAGGAGGGGGGCAT13' Chimera-8/B8:
5'-GGAGTTCCAGTGCCTCTTGTCGATGCCCCGGC-3' Chimera-8/C8: 5-AGGCACTGGAACTCCCAGTGCACCACTACTCACA-3' glycerol, 0.01% bromophenol blue; pH 6.8); @-mercaptoethanol was added to a final concentration of 5%, and the sample was heated at 80°C for 10 min and electrophoresed on reducing 12.5% SDS-polyacrylamide gels. Labeled cells were treated with lysis buffer (PBS, 1% NP40, 1% deoxycholate, 2 mM phenylmethylsulfonyl fluoride), cellular debris was removed by centrifugation, and the extract was immunoprecipitated in the presence of 0.1% SDS. After 10 washes in 0.1% SDS-containing lysis buffer, the samples were electrophoresed as described above. Gels were fixed, enhanced using 2,5-Diphenyloxazole (PPO) (Amersham), dried, and exposed to XAR5 film (Kodak). Quantification analysis was performed by densitometric scanning of autoradiograms (Microscan 1000 densitometer, Technology Resources). Alternatively, slices were cut out of the gel and the radioactivity was determined by scintillation counting. Such estimates based on metabolic labeling were used for the determination of the approximative protein concentrations. No indication of protein instability was observed.
In some experiments, cells were processed for RNA isolation using the single-step procedure (Chomczynski and Sacchi, 1987 5'-TGGATAGCAAAAAA CGAATTGGCTGGAGGTTCCGG-3' Chimera-11 /B 11:
5'-CACACACAGGAAGTGTCTATC-3' Chimera-11 /C 11:
5'-GATAGACACTTCCTGTGTGTG-3' Chimera-12/B 12: 5-TCCCCTCTTAATGGTCAAAGTACACACACAGGCTGT-3' Chimera-12/C12: 5'-TGACCATTAAAAGGGGAAGATGACTTGCCTGCAGGA-3'
Expression in COS-7 cells COS-7 cells were grown to 75% confluency on 60 mm plastic culture dishes and transfected with 5 gg plasmid DNA (twice-banded in CsCl) using the DEAE-dextran-chloroquine method (Luthman and Magnusson, 1983) . The transfected cells were grown for 72 hr in Dulbecco's modified Eagle's medium (DMEM) containing 6% supplemented calf serum (SCS) and 6% horse serum (HS, GIBCO). Subsequently the medium was collected, cleared from cellular debris by high-speed centrifugation, and tested in biological assays.
Metabolic labeling
Bioassays PC12 cells. The chimeric proteins were examined for NGF-like activity on cultures of PC 12 cells. The PC 12 neurite-outgrowth assay was performed as follows. PC12 cells were seeded at a density of lo-20% conlhtency on six-well Costar plastic plates in a volume of 2.5 ml (DMEM, 6% SCS, 6% HS). After allowing cell adherence to the culture dish overnight, serial dilutions (twofold each) of conditioned COS-7 cell supematant were added to replicate wells. Neurite outgrowth was scored after 3 d and compared to parallel standard experiments using twofold dilutions of purified mouse NGF. NGF concentrations of > 1 r&ml scored positive in this assay. Maximal neurite outgrowth was observed at 10-20 rig/ml of NGF.
Chick PNS ganglion explants. To assess each chimera for potential BDNF-like and NGF-like (and possible NT-3-like) activities, the chimeric proteins were compared for their ability to promote neurite outgrowth from explants ofdorsal root ganglia (DRG), nodose ganglia (NG), and sympathetic ganglia (SC) obtained from embryonic day 8 (E8) chicken embryos. Explants of all three ganglionic types (groups of at least six DRG, three NG, and three paravertebral sympathetic chains) were cultured together in collagen gel (Lindsay and Rohrer, 1985) and exposed to the transfected COS-7 cell-conditioned media in 2 ml of F14 medium containing 5% horse serum as described previously . Dose-response analysis was performed by adjusting the added volumes according to the different expression level of the chimeric proteins. Special care was taken always to use corresponding volumes of supematants from vector-only transfected cells as appropriate controls. After 24 hr in culture, fiber outgrowth was determined on an arbitrary scale of 0 to 5 by comparison to a set of photographs taken from a standard dose response of E8 chicken DRG to purified NGF (dosage range, O-20 @ml). A score of 0 indicates no response; a score of 1 indicates detectable activity with an outgrowth of about 10-50 fibers (equivalent to a typical response to 20-l 00 pg/ml purified mouse NGF); a score of 2 indicates moderate activity, with an outgrowth of many fibers in an obvious halo; a score of 3 indicates good activity with the outgrowth of many long fibers; a score of 4 indicates strong activity with an abundant outgrowth of fibers; and a score of 5 indicates massive fiber outgrowth, which is equivalent to a maximal response to saturating levels of NGF (l-l 0 @ml). For an exact description of this arbitrary scale, see Lindsay and Peters (1984) . All experiments were repeated at least three times.
Dissociated chick DRG and NG neurons. Dissociated, neuron-enriched cultures of E8 chicken DRG and E8 chicken NG neurons were established in triplicates as described previously, and the percentage of process-bearing neurons was determined after 48 hr .
Binding assays
Transfected COS-7 cells were grown for 16 hr in DMEM containing 6% SCS and 6% HS and, subsequently, for 48 hr in DMEM plus 0.5% SCS.
The same cells used to collect the conditioned media for biological assays were subsequently metabolically labeled with YS-cysteine in 1.5 ml cysteine-free DMEM containing 1% fetal calf serum for 2 hr. Aliquots of 40 ml of the labeled medium were analyzed directly on 12.5% SDSpolyacrylamide gels under reducing conditions. For immunoprecipitation studies, 500 ~1 of labeled medium was incubated with polyclonal rabbit antisera raised against purified mouse NGF at 4°C for 16 hr and precipitated using Panlorbin cells (Calbiochem) at 4°C for 6 hr. After washing four times in PBS containing 0.5% NP40, the immunocomplexes were eluted into SDS-sample dye (0.0625 M Tris, 2% SDS, 5%
The medium was collected, assayed for biological activity, dialyzed against four changes of 0.02% acetic acid, freeze-dried, and resuspended in 0.01 vol phosphate-buffered saline (PBS). The concentrate was then retested in a quantitative PC 12 bioassay. No loss of activity was observed for any of the chimeric proteins. Binding of each mutant to NGF receptors was measured in a modification of the PC12 cell receptor binding assay (Vale and Shooter, 1985) . Purified mouse NGF was iodinated by the lactoperoxidase method to a specific activity of -1.5 x lo* cpm/pg. lz51-NGF (2 ng) was incubated with increasing amounts of recombinant protein and lo6 PC1 2 cells in a total volume of 100 ~1 at 4°C for 1 hr. After centrifugation through a 0.15 M sucrose gradient, cell pellets were counted in a gamma counter. In the absence of any competitor, the cells bound, on average, 18,000 cpm of lz51-NGF. Two types of controls were incubated in parallel: (1) nonspecific binding was measured in the presence of 2 pg unlabeled NGF, and (2) "vector control" binding was determined by adding increasing amounts of medium from COS-7 cells transfected with the vector pBJ-5 alone. After correction for nonspecific binding, the percentage of lZSI-NGF binding was calculated as the counts per minute from each recombinant competitor divided by the counts per minute from the identical volume of vectortransfected medium, multiplied by 100.
Results
Expression of recombinant NGF in COS-7 cells
We have devised an efficient expression system for recombinant mouse NGF in mammalian cells. The NGF cDNA (encoding the long precursor form using the initiation codon at start site A; Edwards et al., 1986 Edwards et al., , 1988 Selby et al., 1987) was inserted into the mammalian expression vector PBJ-5 (Takebe et al., 1988) and transfected into COS-7 cells. The cell supematant, collected 3 d after transfection, contained 0.5-l Kg of correctly processed NGF (see Fig. 3 ). Western blot analysis combined with neurite outgrowth assays on PC1 2 cells showed no differences in the specific activity of recombinant NGF (in conditioned medium) compared to purified NGF from mouse submaxillary glands (data not shown).
Expression of NGF/BDNF chimeras
A set of 12 chimeric NGF/BDNF molecules was constructed by overlap-extension techniques ( Fig. 1 ) and expressed in COS-7 cells. Substitutions were performed serially in a systematic way by replacing small segments of the NGF amino acid sequence with their respective BDNF counterparts (homologscanning mutagenesis; Fig. 2 , Table 1 ). The exchanged fragments were selected based on interspecies NGF homologies and NGF/ BDNF sequence identities (Fig. 2) . Each of the 12 chimeric proteins was successfully expressed in the COS-7 expression system (Fig. 3) . Direct analysis of metabolically labeled supernatants by SDS-PAGE identified the recombinant proteins migrating at 13 kDa in most of the supematants of chimera-transfected cells (Fig. 3A) . The expression levels were considerably reduced for chimera 4 (weakly detectable in direct supematant analysis) and chimera 5 (not detectable). To enhance the NGFspecific signal, labeled supematants were immunoprecipitated using NGF-specific polyclonal antisera and analyzed by SDS-PAGE (Fig. 3B) . Expression of chimeras 4 and 5 was detectable under these conditions and quantitated to 20% and 3% of the NGF signal, respectively (Table 1) . Quantitative analysis of the results before and after immunoprecipitation (see Materials and Methods) revealed no significant loss of antigenicity in most of the chimeras. Such an analysis was not possible for chimera 5 due to its low level of expression. A minor protein of approximately 32 kDa was also specifically precipitated by NGF antisera from the supematants of cells transfected with an NGFexpression vector or most of the chimeras (Fig. 3B ). This protein CH-l-l 2, chimeras l-l 2. Amino acid exchanges for each chimera are indicated (see Fig. 2B ).
was identified as the NGF precursor protein using antisera raised against NGF precursor-specific synthetic peptides (data not shown; Ebendal et al., 1989) . The precursor of NGF has previously been shown to possess little or no biological activity (Edwards et al., 1988) . In all experiments, comparable transfection efficiencies were ensured by monitoring steady-state NGF/ chimera mRNA levels using quantitative Northern blot analysis (data not shown). To address the question ofwhether the strongly reduced expression of chimeras 4 and 5 was due to intracellular processing or transport problems, appropriately transfected and labeled cells were lysed, immunoprecipitated with NGF antisera, and analyzed on SDS-PAGE. Although the NGF precursor as well as fully processed NGF were readily detected in cells transfected with an NGF-expression vector, considerably less NGF antibody-reactive material was observed in cells transfected with chimera 4 and no specific signal was seen when chimera 5 was examined (data not shown). Although these results indicate that the chimeric proteins do not accumulate to a large extent inside the cells, it cannot be excluded that incorrectly folded and therefore nonimmunoreactive material is present in large amounts within the cells.
Neurite-outgrowth assay on explants from sensory DRG ganglia Both NGF and BDNF (and also NT-3) have been shown to promote neurite outgrowth from explants of E8 chick DRG (Lindsay and Rohrer, 1985; Davies et al., 1986) . Therefore, this assay system was used as an initial screen for the activity of the chimeric NGF/BDNF proteins. The results demonstrate dosedependent neurite outgrowth by recombinant NGF (Fig. 4A ), recombinant BDNF (Fig. 4B) , and all of the chimeric molecules as exemplified by chimera 7 (Fig. 4C) . All of chimeras displayed maximal activity at comparable protein concentrations in this assay system (Table 2) .
Neurite-outgrowth assay on embryonic SC and show, at most, modest outgrowth with NT-3 (Maisonpierre et al., 1990) . Thus, to assess NGF-like specificity of each of the chimeras, the recombinant proteins were tested for their effects on explants of paravertebral chain SC from ES chick embryos.
In agreement with results obtained using purified NGF and BDNF , recombinant NGF was active in this assay while recombinant BDNF was not (Fig. 4A,B) . All the chimeric molecules were found to promote neurite outgrowth on SC explants, and dose-response analysis indicated that similar protein concentrations of the chimeras were needed to obtain a maximal response (Table 2 , Fig. 4C ).
Neurite-outgrowth assay on PC12 cells PC 12 cells differentiate under the influence of NGF into a sympathetic neuron-like cell type (Tischler and Greene, 1975; Greene and Tischler, 1976) . This differentiation process is associated with cessation of cell proliferation and the outgrowth of long neurite extensions. All chimeric proteins as well as NGF were active in causing neurite outgrowth from PC 12 cells, while BDNF was not (Table 1; Squint0 et al., 1991) . These results are in agreement with the findings on explants of SC, which indicated that all the chimeric NGF/BDNF proteins display NGF-like activities. A highly reproducible and quantitative serial-dilution assay on PC 12 cells was used to demonstrate that similar concentrations of most of the chimeras were needed to obtain positive neurite outgrowth. Chimera 1 was an exception. Although this protein was found to be expressed at twofold higher levels than NGF, the specific activity of chimera 1 was significantly and consistently reduced to about 25% in the PC 12 assay system. In addition, chimeras 11 and 12 showed a consistent but small decrease in their respective specific activity (Table 1) .
cells. The approximate positions ofmature NGF and precursor NGF are indicated in kilodaltons (13kD and 32kD.
respectively). B, The supematants from I the same cells as described in A were immunoprecipitated using a polyclonal NGF antiserum and analyzed by SDS-PAGE. Abbreviations are as in A. Figure 4 were performed on explants of E8 DRG, SC, and NG. Neurite-outgrowth values were scored as described in Materials and Methods. The minimal concentrations of NGF, BDNF, and the chimetic proteins needed to reach maximal activity on each type of ganghonic explants are shown. For NGF and all chimeric molecules, the maximal nemiteoutgrowth score on DRG was 5 while saturating concentrations of BDNF on DRG yielded a score of 3 (Fig. 4) . Gn SC, NGF and all chimeric molecules reached a maximal score of 5 (Fig. 4) . The best scores obtained with NGF, BDNF, and the chimeric proteins on NG are indicated in Figure 5 . ND, no detectable activity; -, no activity above the low background observed with NGF (see Fig. 4A ). * The activity of chimera 5 was detectable on DRG and SC at 5 rig/ml (scores of 3 compared to 1 [control supematant]) but not on NG at the same concentration. T T Figure 5 . Effects of chimetic proteins on neurite outgrowth on explants of E8 chick NG. NGF, BDNF, and all chimeras (CH-1-12) were used at optimal concentrations as determined by dose-response curves (see Fig. 4 , Table 2 ). Results are expressed as the mean -+ SEM of triplicate determinations.
Neurite-outgrowth assay on embryonic NG
The chimeric proteins were further characterized using a neurite outgrowth assay on explanted ES chick NG. Most of the chimeras were positive in this system, scoring clearly above the low background observed with NGF (Fig. 5) . Chimeras 2,4,7-10, and 12 reached maximal levels of neurite outgrowth, which were similar to that of recombinant BDNF. Chimeras 3 and 6 were moderately active, whereas chimeras 1 and 11 did not score significantly above background. No activity of chimera 5 was observed in this assay at a concentration that scored clearly positive on DRG and SC (5 @ml). The drastically reduced expression of chimera 5 currently prevents further analysis. More conclusive results concerning chimera 5 will require its purification.
Survival assay on dissociated DRG neurons
Initial dose-response experiments were performed on dissociated E8 chick DRG to determine the concentrations of chimeric proteins necessary to obtain optimal survival. The results demonstrate that all the chimeras promote the survival of sensory DRG neurons, with maximal numbers of surviving neurons (34-58%; Fig. 6 ) comparable to the level reached in the presence of optimal NGF concentrations (54%; Fig. 6 ). None of the chimeras, however (although used at optimal concentrations), led c Figure 4 . Dose-response curves of neurite outgrowth assays on chick ganglionic explants of different neuronal origin. A, Recombinant NGF. B, Recombinant BDNF. C, Chimera 7. SC, E8 sympathetic chain ganglia; DRG, E8 dorsal root ganglia; NG, E8 nodose ganglia. NGF and chimera 7 were added as COS-7 cell supematants. Thus, equivalent volumes of conditioned media derived from vector-only transfected cells were used as controls (curves labeled C). No appreciable background neurite outgrowth was observed. In B, purified recombinant BDNF was used (conditioned medium from BDNF-expressing COS-7 cells showed essentially the same results, but an exact quantification proved to be difficult because of the poor processing of proBDNF to mature BDNF by COS-7 cells; data not shown). Neurite outgrowth scores were determined as described in Materials and Methods. Results are expressed as the mean + SEM of n = 6 DRG or n = 3 SC or NG.
Where no error bar is seen, the scores were identical for each determination at that point.
lto a survival rate close to that observed in the presence of saturating concentrations of both NGF and BDNF together (86%; Fig. 6 ). High concentrations of vector-transfected COS-7 cell supernatant (control) led to some survival of sensory DRG neurons (see Fig. 6 , CH-5). This activity is at least partially due to very low levels of neurotrophin-like activities produced by COS-7 cells (data not shown). Although the experiments described here carefully control for additive effects between the COS-7 cellderived background activity and the produced chimeric proteins (using appropriate concentrations of control supematants), it cannot be formally excluded that synergistic effects could occur in some of the assays.
Survival assay on dissociated NG neurons
Extensive dose-response experiments failed to identify any chimeric molecule that would significantly enhance the survival of dissociated E8 chicken NG neurons. BNDF, however, was significantly active in this assay (Fig. 6 ). Obvious problems such as toxic components in the conditioned medium were excluded by adding purified BDNF to medium from vector-transfected cells, resulting in no loss of BDNF activity in this survival assay system (data not shown). Note that the poorly expressed chimera 5 was not active in this assay at concentrations that resulted in significant specific survival of dissociated DRG neurons.
Competitive binding assay on PC12 cells
In order to obtain a biochemical comparison of the chimeric proteins, competitive binding assays to NGF receptors on PC 12 cells were performed (Vale and Shooter, 1985) . Most of the chimeras were as effective as NGF itself in displacing purified iodinated NGF in this assay system (Fig. 7) . A significant difference was observed with chimera 3, where a fivefold excess of this chimeric protein was necessary for equal displacement compared to NGF. Another peculiarity was seen with chimera 12 (Fig. 7) . Significantly larger amounts of this chimeric protein were necessary to obtain an initial displacement of NGF, and only 50% of bound lZ51-NGF was displaced even at very high concentrations of added competitor. Discussion NGF and BDNF are relatively small, highly basic proteins, each containing six cysteine residues. By extrapolation from the known properties of NGF, it is reasonable to assume that these residues in BDNF, as in NGF, form three intrachain disulfide bridges. Despite lack of information on the three-dimensional structure of any of the neurotrophins, one likely prediction is that even minor modifications to the complex tertiary structures would cause a failure of appropriate folding, resulting in the loss of biological activity. It was anticipated, therefore, that some of the chimeric proteins would have reduced or no NGF-like activity, no biological activity at all, or a gain of BDNF-like activity corresponding with a loss of NGF-like activity. It was surprising to find that essentially all 12 NGF/BDNF chimeras described in this report have the same specific biological activity as NGF in bioassays where NGF scores positive. Thus, an important consequence of the present study is the finding that the construction of chimeric neurotrophic molecules between the members of the neurotrophin family constitutes a feasible approach to explore "active sites," "specificity sites," "active conformations," and so on, of individual members of this family of growth factors. In contrast, attempts to define the active regions of NGF, or to discover peptide agonists of NGF through the synthesis of linear peptide fragments, have been unsuccessful (e.g., Romani et al., 1987) . Whereas the present study has not by itself uncovered which regions of either NGF or BDNF are responsible for their biological activity or their distinct neuronal specificities, it provides a basis for future mutagenesis studies that, coupled with molecular modeling and protein nuclear magnetic resonance studies, will help to establish this information.
Mutagenesis
of NGF The results of this study can be interpreted from two distinct viewpoints. First, the group of recombinant molecules described in this report represents a structural analysis of the NGF protein by in vitro mutagenesis. In contrast to earlier work (Ibbfiez et al., 1990) , which focused on the role of highly conserved amino acids in homologous NGF proteins, this report describes exten- sive mutagenesis of mainly less conserved regions and their possible roles in the structure and function of neurotrophins. The comparison of amino acid sequences of NGF from six different species divides the protein into several stretches of highly conserved versus more variable regions (Fig. 1) . Interestingly, an analogous comparison of mouse NGF and mouse BDNF yields a similar pattern of conservation and variability between these related neurotrophic factors ( Fig. 1 ; Leibrock et al., 1989) . Similar results are obtained if such an analysis includes the third member of the neurotrophin family, NT-3 (Hohn et al., 1990) . These findings provide indirect evidence that the members of the neurotrophin family are structurally related. We have tested this hypothesis experimentally by serially exchanging segments of NGF and BDNF. In this process, the complete sequence of NGF was sequentially replaced by small stretches (8-12 amino acids) of the corresponding BDNF sequence. All the NGF/BDNF chimeras obtained using this procedure retained neurotrophic activity as demonstrated by neurite outgrowth, as well as survival assays on sensory neurons. These results strongly suggest a very close structural relationship between NGF and BDNF. An analysis of the individual chimeras gives some indications of which parts of these molecules are likely to be essential for NGF activity.
Chimera 1. A highly variable region between NGF and BDNF was exchanged in chimera 1. This segment contains mainly amino acids that are not thought to be critically involved in NGF function (Mobley et al., 1976) . Chimera 1 is correctly processed and expressed at an even higher level than NGF (200%), but its specific activity on PC12 cells is significantly reduced. However, no further differences from NGF were observed in other assays, including NGF receptor binding on PC 12 cells. In this context, it is important to note that the competitive binding assay used in this study presumably only measured binding to the LNGFR on PC 12 cells (Vale and Shooter, 1985) . Therefore, more extensive receptor binding studies will be necessary to correlate biological activities with receptor binding (see also below).
Chimera 2. This chimera covers a strongly conserved region within homologous NGF proteins. Comparison to BDNF reveals that only one major alteration was introduced in chimera 2, changing Va120(NGfl to Glu ( I8 BDNm. No significant differences to NGF were observed by testing this chimera on DRG and SC neurons, as well as in binding assays to PC 12 cells. These results would predict that the exchanged segment in chimera 2 may be involved in some basic structural functions that are shared by NGF and BDNF. It is noteworthy that residues contained in this region of NGF may be involved in NGF receptor binding (Iblfiez et al., 1990 ; C. C. Drinkwater, U. Suter, C. Angst, and E. Shooter, unpublished observations).
Chimera 3. This chimera contains an insert of two amino acids that are present in BDNF but missing in all homologous NGF proteins as well as in NT-3. In addition, several other major changes were introduced into the NGF sequence at positions where no variation within homologous NGF proteins are found. Chimera 3 does not differ from NGF in NGF-responsive biological assays. In contrast, there is a striking decrease in efficiency of competitive binding to NGF receptors on PC12 cells by this chimeric protein. We currently have no definitive explanation for this phenomenon, but similar binding characteristics were found with mutations of conserved amino acid residues in NGF (Drinkwater, Suter, Angst, and Shooter, unpublished observations; see also Chimera 1, above).
Chimera 4. The segment exchanged in this chimera includes several substantial differences between NGF and BDNF. However, most of the alterations coincide with residues that also show a high degree of variability within homologous NGF pro-teins. Expression of chimera 4 was comparatively low, but its Chimera 12. This chimera affects the carboxy terminal amino profile of biological activities on DRG and SC neurons was acids of NGF, which are variable between homologous NGF identical to NGF. In addition, no significant differences were proteins. In contrast to BDNF, the mouse NGF protein contains observed in NGF receptor binding. a dibasic cleavage site that is cleaved during NGF processing Chimera 5. This chimera affects a highly variable region bein the mouse submaxillary gland (Server and Shooter, 1977) . tween NGF and BDNF that, in contrast, is rather well conserved However, this cleavage site is not present in all homologous between homologous NGF proteins. This chimeric protein was NGF protein sequences (Schwarz et al., 1989) . Interestingly, poorly expressed in our recombinant expression system. Thus, chimera 12, which contains the C-terminus of BDNF, is much high concentrations of the COS-7 cell-derived neurotrophinless effective in displacing iodinated NGF from NGF receptors like background activity were present in all assays when chimera on PC 12 cells. A similar result was also obtained with chimera 5 was tested (see Fig. 6 ). Nevertheless, our results indicate that 3, but in contrast to chimera 3, some NGF-binding sites on chimera 5 is specifically active in all NGF-responsive biological PC 12 cells could not be competed for even with a several hunassays. However, a more quantitative analysis determining the dred-fold excess of chimera 12 (for discussion, see Chimera 1 exact specific activity of chimera 5 has to await protein purifiand Chimera 3). The biological activity of chimera 12 was sigcation.
nificantly reduced on PC 12 cells, and a special feature was seen Chimera 6. This chimera covers a completely conserved region within homologous NGF, and only one conservative amino acid exchange between NGF and BDNF is found (Phez4cNGfl to Tyr54@DNo. Chimera 6 displays the same activity as NGF in all NGF-specific bioassays as well as in the receptor binding assay. These results indicate that this NGF segment (amino acids 5 l-58) may be critically involved in higher-order protein structures.
Chimera 7. A highly divergent region between NGF and BDNF was exchanged in this chimera. Considering the high variability found in the same amino acid segment between homologous NGF proteins, it was not surprising that chimera 7 showed no differences compared to NGF in NGF-responsive bioassays as well as the binding assay. These results indicate that this amino acid stretch within the NGF and BDNF proteins is not likely to be subjected to structural constraints. Furthermore, the variability in amino acids 59-68 (NGF or BDNF) may prove useful for the introduction of specific antibody epitopes ("tagging") or alterations affecting the stability of neurotrophins in possible clinical applications.
Chimeras 8 and 9. The amino acid segments exchanged between NGF and BDNF in these two chimeras are mainly conserved, and most of the variable residues coincide with the differences between homologous NGF proteins. It was therefore predicted and experimentally confirmed that these mutant proteins would act like NGF in their binding to NGF receptors as well as in NGF-responsive bioassays.
Chimera 10. This chimera covers a segment of NGF and BDNF that is highly variable between the two growth factors as well as between homologous NGF proteins. Furthermore, this mutation also results in the insertion of an additional amino acid into the NGF sequence. Despite these large changes, no significant differences of chimera 10 were observed compared to NGF when tested on DRG and SC neurons or in NGF receptor binding assays. These results would suggest that at least the variable amino acids 92-97 (NGF or BDNF) are not likely to be involved in rigorous higher-order protein structures.
in the neurite outgrowth assay on DRG. It has been commonly found that high concentrations of NGF are inhibitory to neurite outgrowth from DRG explants, although neuronal survival is equal at high or low NGF concentrations. Similar bell-shaped dose-response curves on DRG explants were seen with all NGF/ BDNF chimeric proteins except chimera 12. The latter showed little inhibitory effect at concentrations two orders of magnitude above that which elicited a maximum fiber outgrowth (data not shown). Further studies using purified protein will be needed to follow up on this phenomenon. In summary, these results suggest that the entire structure or conformation of NGF, and not small amino acid segments within the protein, determine its neurotrophic activity.
The relationship between NGF-and BDNF-like biological activities A second view of the molecules described in this report is based on their chimeric nature (NGF/BDNF chimeras). These recombinant proteins were derived from two related neurotrophic factors that show distinct neuronal specificities on certain target cells but possible overlap on others. In an attempt to elucidate the structural basis for the differential neuronal specificities of NGF and BDNF, we have systematically replaced small amino acid segments covering the complete mature NGF molecule by their respective BDNF counterparts. In an ideal situation, as described in other reports using similar strategies to identify receptor binding sites and antibody epitopes (Cunningham et al., 1989; Lamarre et al., 1989) this would lead to the discovery of one inserted fragment that would be found to confer the specificity of the donor (e.g., BDNF) to the acceptor (e.g., NGF). Such a result is only to be expected if indeed there is a small, linear amino acid segment of BDNF (or NGF) that is responsible for neuronal specificity. Depending on the structural basis that distinguishes NGF from BDNF, such a chimeric molecule would, or would not, loose its NGF-like activity. With this objective in mind, we tested all chimeric proteins in several bioassays, which taken together permit a distinction between NGF-and BDNF-like activity. All chimeras were found to be active in a neurite outgrowth assay using explanted chick embryo DRG, as well as survival assays using dissociated DRG neurons. These assays do not discriminate between NGF-and BDNF-like activity but establish that all 12 chimeric proteins are biologically active in vitro. All 12 chimeric proteins also promote vigorous neurite outgrowth from explants of E8 chick SC, with maximal responses seen at protein concentrations comparable to that observed in the DRG assay. NGF is the only member of the neurotrophin family known so far that elicits massive neurite Chimera I I. Only one major amino acid difference, Ala107(Ncm to SerlO*(BDNF), occurs between NGF and BDNF within the segment exchanged in chimera 11. This mutant protein exhibited comparatively lower expression in COS-7 cells and decreased activity on PC12 cells, but no other significant changes were observed in biological activities, as well as in receptor binding, when compared to NGF. The high degree ofconservation within the exchanged segment indicates a structural role of this amino acid stretch, and the marginal differences seen in comparison to NGF on PC 12 cells may be significant, but will require protein purification for further clarification.
outgrowth from explants of chick SC. BDNF and NT-4 have no neurite-promoting action toward these neurons, and NT-3 has only a relatively small effect on SC explants (Maisonpierre et al., 1990) . We conclude from these results that all the chimeric proteins retain their NGF-like activities. These findings were confirmed using the NGF-specific PC12 neurite outgrowth assay.
To assess any BDNF-like activity of the chimeric proteins, neurite-outgrowth assays were performed on explants of chick embryo NG. All chimeras except 1 and 11 (and possibly 5) showed activities significantly above the low background observed with NGF when used at concentrations similar to the DRG and SC explant assays. These nine chimeras have acquired, therefore, a significant specific BDNF-like activity as defined by neurite outgrowth from NG. That almost all the chimeric proteins display some BDNF-like activity was surprising, given that some of the chimeras contained only conservative amino acid changes and chimera 6 represented a single amino acid mutation. However, when looked at from the perspective of BDNF specificity, it should be kept in mind that the primary structure of BDNF has been found to be 100% conserved in all mammals examined to date (mouse, rat, pig, and human; Maisonpierre et al., 199 1) . This would suggest that even small changes in the primary structure of BDNF may lead to loss of specificity, reduction of specific activity, or gain of additional activities. If indeed such a variety of changes in NGF, as exhibited by the chimeric proteins described in this study, almost always results in the gain of some BDNF-like activity, it would indicate that the specificity of NGF, and perhaps the neurotrophins in general, lies more in the overall tertiary structure or quarternary structure than in discrete epitopes. In addition, although we refer to the activity on NG as "BDNF-like," NT-3 also shows activity toward these neurons (Hohn et al., 1990; Maisonpierre et al., 1990) . Depending on how large the neurotrophin family is eventually found to be, it is conceivable that some of the present chimeric proteins will prove to be closer in specificity to as yet undiscovered members of the neurotrophin family than they are to BDNF. The present results are further complicated by the fact that sensory ganglia contain several different subpopulations of neurons as defined by size, sensory modality, and chemical phenotype. It is thus not clear that the neurite outgrowth induced in the NG by BDNF or many of the chimeras represents neurite outgrowth from the same or different subpopulations of NG neurons. To answer these questions, more specific assays will be required.
Surprisingly, none of the chimeras showed appreciable activity in promoting the survival of dissociated NG neurons, an assay in which BDNF is active while NGF is not. The lack of BDNF-like survival-supporting activity was further substantiated by the finding that none of the chimeras at saturating protein concentrations supported the survival of a higher percentage of dissociated DRG-derived neurons than NGF alone. Given the fact that NGF and BDNF in combination supported the survival of nearly all DRG neurons in vitro, similar results would be expected of a true chimera possessing dual NGF-and BDNFlike activities. In summary, our findings suggest that most of the chimeric proteins acquire some but not all of the activity of the parental BDNF molecule while retaining their NGF-like activity.
In seeking an explanation for these results, two observations are pertinent. First, it is known that different molecular cascades are involved in NGF-dependent neurite outgrowth and NGFdependent neuronal survival of SC and sensory neurons (Greene et al., 1990) . It is conceivable that similar alternative pathways are differentially activated by the chimeric molecules that display BDNF-dependent neurite outgrowth but no BDNF-dependent neuronal survival. Second, it is now clear that NGF binds to at least two separate receptor proteins, the LNGFR, p80LNGFR (Johnson et al., 1986; Radeke et al., 1987) , and the trk protooncogene, pp13Srk (Kaplan et al., 199 1; Klein et al., 199 1; Meakin and Shooter, 1991a,b) . Opinions differ as to whether trk by itself is the biologically active NGF receptor or whether the latter consists of a complex of the two NGF-receptor species (Hempstead et al., 199 1; Klein et al., 199 1; Weskamp and Reichard& 1991) . The observations that NGF, BDNF, and NT-3 all bind to p80LNGFR with the same equilibrium constant but with different kinetics (Rodriguez-Tkbar et al., 199 1; Squint0 et al., 1991) support the idea that the high-affinity neurotrophin receptors are complexes of p80LNGFR and one of the members of the trk protein family, with the latter determining, at least in part, the specificity of the particular neurotrophic factor. Depending on the nature of the interactions between p80LNGFR and the trk proteins, some of the chimeras may activate specific signal pathways, mimicking both NGF and BDNF with respect to neurite outgrowth but only NGF with respect to neuronal survival. The availability of the cloned p80LNGFR and the members of the trk family will allow the expression of these receptor proteins alone or in combination in heterologous systems and will provide the tools to use this set of chimeric NGF/BDNF proteins to gain further insight into the differential activities of the neurotrophins. Alternatively, it is conceivable that some of the NGF/BDNF chimeras mimic other members of the neurotrophin family which, as yet, either are poorly characterized (like NT-4) or await discovery.
Note added in proof While this manuscript was under review, Ib&ez et al. (199 1) reported the construction of a different set of NGF-BDNF chimeras. The authors concluded, in agreement with the results shown here, that the specificity of NGF appears to depend more on the overall shape or conformation of the protein than on specific small amino acid segments.
